Evidence map›Paper›PMID 36181350›Full record

ArticleTissue engineering. Part A2023

Programming the Self-Organization of Endothelial Cells into Perfusable Microvasculature.

Katelyn A Cabral, Vasudha Srivastava, Austin J Graham, Maxwell C Coyle, Connor Stashko, Valerie Weaver, Zev J Gartner

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Clustered macrophages cooperate to eliminate tumors via coordinated intrudopodia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Katelyn A CabralGraduate Program in Bioengineering, University of California, San Francisco and University of California, Berkeley, Berkeley, California, USA.
Vasudha SrivastavaDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.
Austin J GrahamDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.
Maxwell C CoyleDepartment of Molecular and Cellular Biology, University of California, Berkeley, Berkeley, California, USA.
Connor StashkoGraduate Program in Bioengineering, University of California, San Francisco and University of California, Berkeley, Berkeley, California, USA.
Valerie WeaverCenter for Bioengineering and Tissue Regeneration, Department of Surgery, University of California, San Francisco, San Francisco, California, USA.
Zev J GartnerDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0001-7803-1219
University of California, San Francisco · USUniversity of California, Berkeley · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
Tissue mechanics reprograms the tissue to malignancy and metastasisR35CA242447 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALERIE MARIE WEAVER · 2020 to 2026
$6.6M
Integrative approach to heterogeneity in breast cancer metastasisU01CA199315 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI, SPELLMAN, PAUL T. · 2016 to 2020
$3.2M
Understanding breast cancer progression as a defect in the mechanics of tissue self-organizationU01CA244109 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN, GOGA, ANDREI · 2020 to 2024
$3.0M
Total synthesis of the human mammary glandDP2HD080351 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN · 2013 to 2013
$2.4M
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic LeukemiaR01CA190843 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI FEUSNER, JAMES, SOHN, LYDIA L · 2015 to 2019
$1.6M
Isolating Circulating Tumor CellsR21CA182375 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI SOHN, LYDIA L · 2015 to 2017
$605k
Node-Pore Sensing for Cellular ScreeningR21EB019181 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI LUSTIG, MICHAEL, SOHN, LYDIA L · 2015 to 2016
$409k
NCI NIH HHS P30 CA082103NCI NIH HHS R01 CA190843NCI NIH HHS R21 CA182375NCI NIH HHS R35 CA242447NCI NIH HHS U01 CA199315NCI NIH HHS U01 CA244109NIBIB NIH HHS R21 EB019181NICHD NIH HHS DP2 HD080351
6 · The paper itself

Abstract

The construction of three-dimensional (3D) microvascular networks with defined structures remains challenging. Emerging bioprinting strategies provide a means of patterning endothelial cells (ECs) into the geometry of 3D microvascular networks, but the microenvironmental cues necessary to promote their self-organization into cohesive and perfusable microvessels are not well known. To this end, we reconstituted microvessel formation

Indexed as

Endothelial CellsNeovascularization, PhysiologicExtracellular MatrixMicrovesselsTissue Engineeringbioprintingcell behaviorcell patterningengineered microvasculatureengineered tissuesmicroenvironmentoptimizationtissue morphogenesisvasculogenesis

Identifiers

PMID36181350
PMCPMC10266707
OpenAlexW4298326588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.